These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 17343775)
1. Mechanisms of the components of the metabolic syndrome that predispose to diabetes and atherosclerotic CVD. Eckel RH Proc Nutr Soc; 2007 Feb; 66(1):82-95. PubMed ID: 17343775 [TBL] [Abstract][Full Text] [Related]
3. The dysmetabolic syndrome, insulin resistance and increased cardiovascular (CV) morbidity and mortality in type 2 diabetes: aetiological factors in the development of CV complications. Eschwège E Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S19-27. PubMed ID: 14502097 [TBL] [Abstract][Full Text] [Related]
4. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance. Højlund K Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125 [TBL] [Abstract][Full Text] [Related]
5. Relationships between adiponectin levels, the metabolic syndrome, and type 2 diabetes: a literature review. Frankenberg ADV; Reis AF; Gerchman F Arch Endocrinol Metab; 2017 Dec; 61(6):614-622. PubMed ID: 29412387 [TBL] [Abstract][Full Text] [Related]
6. Should the insulin resistance syndrome be treated in the elderly? Grant RW; Meigs JB Drugs Aging; 2004; 21(3):141-51. PubMed ID: 14979733 [TBL] [Abstract][Full Text] [Related]
7. The effect of increasing body mass index on cardio-metabolic risk and biomarkers of oxidative stress and inflammation in nascent metabolic syndrome. Pahwa R; Adams-Huet B; Jialal I J Diabetes Complications; 2017 May; 31(5):810-813. PubMed ID: 28285929 [TBL] [Abstract][Full Text] [Related]
14. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome. Nesto RW Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526 [TBL] [Abstract][Full Text] [Related]
15. Diabetes and branched-chain amino acids: What is the link? Bloomgarden Z J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529 [TBL] [Abstract][Full Text] [Related]
16. [Pathogenic role of hyperinsulinism in macroangiopathy. Epidemiological data]. Valensi P Presse Med; 1992 Sep; 21(28):1307-11. PubMed ID: 1438099 [TBL] [Abstract][Full Text] [Related]
17. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468 [TBL] [Abstract][Full Text] [Related]
18. [Diabetic dyslipidaemia and the atherosclerosis]. Márk L; Dani G Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274 [TBL] [Abstract][Full Text] [Related]
19. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757 [TBL] [Abstract][Full Text] [Related]